Skip to main content

Providence Capital Advisors, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1730814 CHARLOTTE, NC

Position in GILD

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$37,396
+$1,345 QoQ
Shares Held
296
-31.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#2,088
of 2,266 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Providence Capital Advisors, LLC holds $29,086,080 across 11 Drug Manufacturers - General names. GILD ranks #11 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in GILD

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $37,396 296
2024-09-30 $36,051 430
2024-06-30 $29,433 429
2024-03-31 $31,351 428
2023-12-31 $34,591 427
2023-09-30 $31,924 426
2023-06-30 $32,677 424
2023-03-31 $17,340 209
2022-12-31 $17,942 209
2022-09-30 $12,831 208
2022-06-30 $13,412 217
2022-03-31 $6,836 115
2021-12-31 $8,277 114
2021-09-30 $8,032 115
2021-06-30 $4,359,802 63,314
2021-03-31 $3,924,527 60,723
2020-12-31 $3,414,152 58,602
2020-09-30 $2,963,737 46,902
2020-06-30 $2,862,321 37,202
2020-03-31 $3,483,816 46,600